Marianne Mancini
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Marianne Mancini
Marianne Mancini is recorded as COO at Viking Therapeutics, Inc. (VKTX). The proxy statement of Viking Therapeutics, Inc. reports total compensation of $5,162,872 for Marianne Mancini in fiscal 2025, including a base salary of $540,000. Disclosed compensation is on record for 5 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Viking Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian Lian CEO, Board Member
- Greg Zante CFO
- Brian Lian, Ph.D. Board Member
- Charles A. Rowland Board Member
- J. Matthew Singleton Board Member
- Lawson Macartney, Ph.D. Board Member
- Matthew W. Foehr Board Member
- S. Kathryn Rouan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Viking Therapeutics, Inc. (VKTX) | Chief Operating Officer | $540,000 | $5,162,872 |
| 2024 | Viking Therapeutics, Inc. (VKTX) | Chief | $490,000 | $4,703,394 |
| 2023 | Viking Therapeutics, Inc. (VKTX) | Chief | $465,000 | $3,510,957 |
| 2022 | Viking Therapeutics, Inc. (VKTX) | Chief | $446,000 | $2,052,044 |
| 2021 | Viking Therapeutics, Inc. (VKTX) | Chief Operating Officer | $405,000 | $1,507,624 |
Recent activity
No call appearances or filed executive changes recorded yet.